Sort
51,593 grants matching “hepatitis”
Management/Hepatitis C/HIV-infected and Uninfected IDU's
$514,380Johns Hopkins University · R01 · FY2003 · DA
Inflammation as a Mediator of Dynamic DNA Mutations
$514,365Sarah Delaney · Brown University · R01 · FY2011 · ES
Determining hepatocyte-specific mechanisms by which Ube4A regulates NAFLD/NASH
$514,249Anutosh Chakraborty · Saint Louis University · R01 · FY2023 · DK
Epidemiologic Study of the Effectiveness of an ADF in Reducing Opioid Abuse
$514,183Jennifer R Havens · University Of Kentucky · R01 · FY2014 · DA
Aflatoxin Biosynthesis and Iterative Type I Polyketide Synthases
$514,167Craig A Townsend · Johns Hopkins University · R01 · FY2008 · ES
Evaluation of HCC Response to Systemic Therapy with Quantitative MRI
$514,057Bachir Taouli · Icahn School Of Medicine At Mount Sinai · U01 · FY2016 · CA
HEPADNAVIRUS INFECTIONS AND LIVER CANCER
$513,985Institute For Cancer Research · R01 · FY2004 · AI
Endovascular Chemofiltration: Optimizing Removal of Chemotherapeutics and Nanoparticles from the Blood to Reduce Toxicity
$513,934Steven William Hetts · University Of California, San Francisco · R01 · FY2017 · CA
DETERMINANTS OF HEPATITIS C &E MORBIDITY IN EGYPT
$513,919University Of Maryland Baltimore · U01 · FY2004 · AI
Multi-level analysis of iron metabolism and treatment of chronic kidney disease
$513,916Paul L Fox · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · DK
Prediction of portal pressure with liver and spleen MR Elastography and 4D flow phase-contrast MRI
$513,907Bachir Taouli · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · DK
Identification and characterization of cellular factors involved in HCV entry
$513,873Charles M. Rice · Rockefeller University · R01 · FY2013 · AI
SGLT2 Inhibition and Stimulation of Endogenous Glucose Production
$513,780Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2020 · DK
Liver Tissue and Cell Distribution System
$513,654Glenn Gourley · University Of Minnesota · N01 · FY2016 · LM
SGLT2 Inhibition and Stimulation of Endogenous Glucose Production
$513,574Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2017 · DK
Intervention to Reduce Injection Drug Use
$513,543Robert E Booth · University Of Colorado Denver · R01 · FY2010 · DA
Extracellular vesicles as the vehicles for promoting liver injury induced by HIV and alcohol
$513,541Natalia Aleksandr Osna · University Of Nebraska Medical Center · R01 · FY2022 · AA
Mechanistic roles of Cytochrome P4501A enzymes in hyperoxic lung injury
$513,432Bhagavatula Moorthy · Baylor College Of Medicine · R01 · FY2019 · HL
Mechanistic roles of Cytochrome P4501A enzymes in hyperoxic lung injury
$513,423Bhagavatula Moorthy · Baylor College Of Medicine · R01 · FY2018 · HL
Immunology of Acute and Chronic Viral Hepatitis in Humans
$513,415Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK
The Host Response to Hepatitis C Virus
$513,411Michael J Gale · University Of Washington · R01 · FY2016 · AI
ROLES OF NEOGENIN AND MATRIPTASE-2 IN IRON HOMEOSTASIS
$513,385An-Sheng Zhang · Oregon Health & Science University · R01 · FY2023 · DK
ROLES OF NEOGENIN AND MATRIPTASE-2 IN IRON HOMEOSTASIS
$513,385An-Sheng Zhang · Oregon Health & Science University · R01 · FY2022 · DK
ROLES OF NEOGENIN AND MATRIPTASE-2 IN IRON HOMEOSTASIS
$513,385An-Sheng Zhang · Oregon Health & Science University · R01 · FY2021 · DK
ROLES OF NEOGENIN AND MATRIPTASE-2 IN IRON HOMEOSTASIS
$513,385An-Sheng Zhang · Oregon Health & Science University · R01 · FY2020 · DK